Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients

por Gabasa, M, Ikemori, R, Hilberg, F, Reguart, N, Alcaraz, J
Publicado 2017

CD44 regulates bone erosion and osteoclastogenesis in arthritis

por Hayer, S, Goertz, B, Zwerina, J, Redlich, K, Hoffmann, O, Amling, M, Hilberg, F, Kollias, G, Steiner, G, Wagner, EF, Smolen, JS, Schett, G
Publicado 2004

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)

por Quintela-Fandino, M, Urruticoechea, A, Guerra, J, Gil, M, Gonzalez-Martin, A, Marquez, R, Hernandez-Agudo, E, Rodriguez-Martin, C, Gil-Martin, M, Bratos, R, Escudero, M J, Vlassak, S, Hilberg, F, Colomer, R
Publicado 2014